Investors might want to bet on Invesco (IVZ) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Indivi ...

Core Viewpoint - Gray Media (GTN) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with stock price movements [4][6]. - For Gray Media, the recent upgrade reflects an improvement in the company's underlying business, likely leading to increased stock prices due to investor confidence [5][10]. Earnings Estimate Revisions - Over the past three months, the Zacks Consensus Estimate for Gray Media has increased by 17.9% for the fiscal year ending December 2025, with expected earnings of -$1.45 per share, unchanged from the previous year [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - The upgrade of Gray Media to Zacks Rank 1 places it in the top 5% of Zacks-covered stocks, indicating strong potential for market-beating returns in the near term [10].

分组1 - Carter Bankshares, Inc. reported quarterly earnings of $0.41 per share, exceeding the Zacks Consensus Estimate of $0.33 per share, and showing an increase from $0.37 per share a year ago, resulting in an earnings surprise of +24.24% [1] - The company posted revenues of $39.99 million for the quarter ended December 2025, which was 2.52% below the Zacks Consensus Estimate, compared to $34.7 million in revenues from the previous year [2] - Over the last four quarters, Carter Bankshares has surpassed consensus EPS estimates three times, but has only topped consensus revenue estimates once [2] 分组2 - The stock has gained approximately 1.3% since the beginning of the year, while the S&P 500 has increased by 1.9% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $0.38 on revenues of $40.93 million, and for the current fiscal year, it is $1.90 on revenues of $174.02 million [7] 分组3 - The Zacks Industry Rank indicates that the Banks - Northeast sector is in the top 23% of over 250 Zacks industries, suggesting a favorable outlook for stocks in this category [8] - Another company in the same industry, Meridian Bank, is expected to report quarterly earnings of $0.55 per share, reflecting a year-over-year increase of +12.2%, with revenues projected at $32.18 million, up 12.6% from the previous year [9]

First Mid Bancshares (FMBH) came out with quarterly earnings of $1.06 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.87 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +0.24%. A quarter ago, it was expected that this bank holding company would post earnings of $0.96 per share when it actually produced earnings of $0.97, delivering a surprise of +1.04%.Over the last four quarters, the com ...

Core Viewpoint - Pfizer is expected to report a decline in quarterly earnings and revenues, indicating challenges in its financial performance compared to the previous year [1]. Financial Performance - Quarterly earnings per share (EPS) are predicted to be $0.57, a decrease of 9.5% year-over-year [1]. - Revenues are forecasted at $16.93 billion, reflecting a year-over-year decrease of 4.7% [1]. Earnings Estimate Revisions - There has been a 2% downward revision in the consensus EPS estimate over the last 30 days, indicating analysts' reassessment of their forecasts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3]. Revenue Estimates by Segment - Revenues from Oncology (Ibrance) are expected to reach $1.03 billion, down 6.1% from the prior year [5]. - Specialty Care (Xeljanz) revenues are estimated at $335.30 million, a decrease of 3.9% year-over-year [5]. - Specialty Care (Inflectra) revenues are projected at $173.25 million, showing a significant increase of 36.4% year-over-year [6]. - Oncology (Xtandi) revenues are expected to be $622.10 million, reflecting a 10.1% increase from the previous year [6]. Regional Revenue Insights - U.S. revenues for Oncology (Ibrance) are estimated at $665.80 million, down 6.6% from the year-ago quarter [7]. - Total international revenues for Specialty Care (Xeljanz) are expected to be $112.62 million, indicating a 12% decline year-over-year [7]. - U.S. revenues for Specialty Care (Inflectra) are projected at $150.80 million, a substantial increase of 135.6% year-over-year [8]. - Pfizer CentreOne revenues in the U.S. are estimated at $92.82 million, reflecting a 13.2% increase from the prior year [9]. Overall Market Performance - Pfizer shares have returned +3.9% over the past month, outperforming the Zacks S&P 500 composite's +0.8% change [10]. - With a Zacks Rank of 5 (Strong Sell), Pfizer is expected to underperform the overall market in the near future [10].

Core Viewpoint - Bankwell Financial Group, Inc. reported quarterly earnings of $1.15 per share, missing the Zacks Consensus Estimate of $1.20 per share, but showing significant growth from $0.32 per share a year ago, indicating a -4.17% earnings surprise [1] Financial Performance - The company posted revenues of $30.32 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 8.72%, compared to $21.16 million in the same quarter last year [2] - Over the last four quarters, Bankwell Financial Group has exceeded consensus revenue estimates three times [2] Stock Performance - Bankwell Financial Group shares have increased by approximately 2.6% since the beginning of the year, outperforming the S&P 500's gain of 1.9% [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $1.18 for the coming quarter and $5.10 for the current fiscal year, alongside revenues of $27.58 million and $117.84 million respectively [7] - The Zacks Rank for Bankwell Financial Group is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Banks - Northeast industry, to which Bankwell Financial Group belongs, is currently ranked in the top 23% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

分组1 - Norfolk Southern reported quarterly earnings of $3.22 per share, exceeding the Zacks Consensus Estimate of $2.78 per share, and showing an increase from $3.04 per share a year ago, resulting in an earnings surprise of +15.92% [1] - The company posted revenues of $2.97 billion for the quarter ended December 2025, which was below the Zacks Consensus Estimate by 0.87%, and a decrease from $3.02 billion in the same quarter last year [2] - Over the last four quarters, Norfolk Southern has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] 分组2 - The stock has underperformed the market, losing about 1.5% since the beginning of the year compared to the S&P 500's gain of 1.9% [3] - The current consensus EPS estimate for the upcoming quarter is $2.78 on revenues of $3.03 billion, and for the current fiscal year, it is $12.77 on revenues of $12.55 billion [7] - The Transportation - Rail industry, to which Norfolk Southern belongs, is currently ranked in the bottom 17% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Core Insights - Corteva, Inc. (CTVA) is expected to report quarterly earnings of $0.21 per share, reflecting a decline of 34.4% year-over-year, while revenues are forecasted to reach $4.23 billion, indicating a 6.3% increase compared to the previous year [1] Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised downward by 3.3%, indicating a collective reassessment by analysts of their initial forecasts [2] - Revisions to earnings projections are crucial for predicting investor behavior, as empirical studies show a strong correlation between earnings estimate trends and short-term stock performance [3] Revenue Projections - Analysts estimate 'Revenue- Crop Protection' to be $2.42 billion, a year-over-year increase of 9.8% [5] - 'Revenue- Seed' is projected to reach $1.82 billion, reflecting a 2.6% increase year-over-year [5] - 'Revenue- Seed- Other oilseeds' is expected to be $89.86 million, indicating a 3.3% increase from the previous year [5] Segment Analysis - 'Revenue- Crop Protection- Herbicides' is forecasted at $1.14 billion, a 10.9% increase year-over-year [6] - 'Revenue- Crop Protection- Insecticides' is expected to reach $557.11 million, reflecting a 13.7% increase [6] - 'Revenue- Crop Protection- Fungicides' is projected at $357.43 million, indicating an 11.7% year-over-year change [6] Additional Revenue Insights - 'Revenue- Crop Protection- Other' is estimated at $213.87 million, a 9.1% increase year-over-year [7] - 'Revenue- Seed- Soybean' is expected to be $155.13 million, showing a slight increase of 0.7% [7] - 'Revenue- Seed- Corn' is projected to reach $1.41 billion, indicating a minor decline of 0.1% [7] Operating Metrics - 'Operating EBITDA- Seed' is expected to be $106.13 million, compared to $93.00 million from the previous year [8] - 'Operating EBITDA- Crop Protection' is projected at $430.49 million, down from $461.00 million year-over-year [8] Market Performance - Corteva, Inc. shares have returned +9% over the past month, outperforming the Zacks S&P 500 composite, which saw a +0.8% change [9] - The company holds a Zacks Rank 1 (Strong Buy), indicating expectations to outperform the overall market in the near future [9]

Core Insights - Ametek (AME) is expected to report quarterly earnings of $1.94 per share, reflecting a 3.7% increase year-over-year, with revenues projected at $1.95 billion, indicating a 10.5% year-over-year growth [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate for Ametek has been revised upward by 1.4%, indicating analysts' reassessment of their initial forecasts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Key Metrics Projections - Analysts estimate 'Net Sales - Electronic Instruments' to reach $1.34 billion, representing a 9.9% year-over-year increase [5]. - 'Net Sales - Electromechanical' is projected to be $603.75 million, indicating a 10.4% year-over-year growth [5]. - The average prediction for 'Operating Income - Electronic Instruments' is $398.70 million, compared to $386.65 million from the previous year [5]. - 'Operating Income - Electromechanical' is expected to reach $139.63 million, up from $111.19 million year-over-year [6]. Stock Performance - Ametek shares have shown an 8.4% return over the past month, outperforming the Zacks S&P 500 composite, which increased by 0.8% [6]. - Ametek holds a Zacks Rank 2 (Buy), suggesting it is expected to outperform the overall market in the near future [6].

Core Viewpoint - Coastal Financial Corporation (CCB) reported quarterly earnings of $0.82 per share, missing the Zacks Consensus Estimate of $1.16 per share, representing a -29.00% earnings surprise [1]. Financial Performance - The company posted revenues of $138.03 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 14.06%, compared to year-ago revenues of $143.27 million [2]. - Over the last four quarters, Coastal Financial has not surpassed consensus EPS estimates and has topped consensus revenue estimates only once [2]. Stock Performance - Coastal Financial shares have declined approximately 11.9% since the beginning of the year, while the S&P 500 has gained 1.9% [3]. - The current Zacks Rank for Coastal Financial is 4 (Sell), indicating expected underperformance in the near future [6]. Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.27 on revenues of $164.4 million, and for the current fiscal year, it is $6.06 on revenues of $716.2 million [7]. - The trend of estimate revisions for Coastal Financial was unfavorable prior to the earnings release, which may impact future stock movements [5][6]. Industry Context - The Zacks Industry Rank for Banks - West is in the top 21% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8]. - Sierra Bancorp, another company in the same industry, is expected to report quarterly earnings of $0.85 per share, reflecting a year-over-year change of +18.1% [9].